The National Heart, Lung, and Blood Institute (NHLBI) has released the first comprehensive, evidence-based guidelines for management of sickle cell disease from birth to end of life, based on ...

DALLAS – September 9, 2014– The National Heart, Lung, and Blood Institute (NHLBI) has released the first comprehensive, evidence-based guidelines for management of sickle cell disease from ...

September is National Sickle Cell Awareness Month.The congressional designation is intended to focus attention on the need for improved treatments and additional research for the condition, which ...

Early and aggressive treatment of acute sickle cell pain may reduce the development of chronic pain,” the panel writes. The panel's literature search turned up 12,532 references for initial review.

NHLBI's sickle cell branch chief and senior investigator Swee Lay Thein is leading the trial, which is being conducted at the NIH Clinical Center in Bethesda, Maryland.

For the first time scientists have corrected sickle cell disease in mice using gene therapy, according to a study supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National ...

Researchers have identified a gene that directly affects the production of a form of hemoglobin that is instrumental in modifying the severity of the inherited blood disorders sickle cell disease ...

Each year, some 150,000 children in Nigeria are born with sickle cell disease, the most common — and often life-threatening — inherited blood disorder in the world.